R&D News | pharmaphorum

News

HCP looking at ECG graph for heart health

Could an ECG spot people at risk of cognitive decline?

UK Biobank study suggests someone's risk of premature ageing or cognitive decline could be predicted using a simple ECG reading supported by an AI.

News

Takeda CEO succession confirmed as Weber plans retirement

Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker.

News

Troubled 23andMe is exploring a sale of the business

Genetic testing specialist 23andMe has launched a strategic review that could result in a sale of the company.

News

AI in medical imaging company Quibim raises $50m

Quibim has raised $50 million in first-round financing to support the rollout of its AI biomarkers for use in the analysis of medical imaging.

News

Sage rejects Biogen takeover and launches review

Sage Therapeutics has unanimously rejected Biogen's acquisition offer of around $469 million, saying it "significantly undervalues" the company.

News

Veru shares plunge despite positive data in obesity trial

Veru's obesity candidate achieved the objective of preserving muscle in people taking weight-loss drug Wegovy, but its share price still fell sharply.

Could an ECG spot people at risk of cognitive decline?

Takeda CEO succession confirmed as Weber plans retirement

Troubled 23andMe is exploring a sale of the business

AI in medical imaging company Quibim raises $50m

Sage rejects Biogen takeover and launches review

Veru shares plunge despite positive data in obesity trial

Aspen, Bambusa close IPOs as Corxel takes SPAC route

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks